Hepatosplenic T cell lymphoma medical therapy

Revision as of 14:22, 23 February 2016 by Sowminya Arikapudi (talk | contribs)
Jump to navigation Jump to search

Hepatosplenic T cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Hepatosplenic T cell lymphoma from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatosplenic T cell lymphoma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatosplenic T cell lymphoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatosplenic T cell lymphoma medical therapy

CDC on Hepatosplenic T cell lymphoma medical therapy

Hepatosplenic T cell lymphoma medical therapy in the news

Blogs on Hepatosplenic T cell lymphoma medical therapy

Directions to Hospitals Treating Hepatosplenic T cell lymphoma

Risk calculators and risk factors for Hepatosplenic T cell lymphoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

The predominant therapy for hepatosplenic T cell lymphoma is chemotherapy. Adjunctive stem cell transplant (SCT) may be required.

Medical Therapy

Treatment of hepatosplenic T cell lymphoma[1]
Therapy Description
Chemotherapy
Stem cell transplant
  • A stem cell transplant (SCT) may be an option for some people with hepatosplenic T cell lymphoma

References

Template:WikiDoc Sources